CTOs on the Move

Mortara Instrument

www.mortara.com

 
Founded in 1982 by David W. Mortara, PhD, Mortara Instrument was born with a guiding philosophy: design to a need, keep it simple, and make it economically accessible. Building on this philosophy, Mortara Instrument has created a complete line of
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.mortara.com
  • 7865 N 86th St
    Milwaukee, WI USA 53224
  • Phone: 414.354.1600

Executives

Name Title Contact Details

Similar Companies

STAT PADS

STAT PADS is a Boise, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MacuLogix

MacuLogix is the only company to leverage the science of dark adaptation to help eliminate preventable blindness caused by AMD.

Integrity Applications

Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea.

Plantex USA

Plantex USA is a Woodcliff Lake, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Astellas Gene Therapies

Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina.